LC3 AND BECLIN 1 AS MARKERS OF AUTOPHAGIC ACTIVITY IN BREAST CANCER

NURSULTAN NURDİNOV, VENHAR ÇINAR, AHSEN GÜLER, SEVDA GÖKÇE YILMAZ, NESRİN DELİBAŞI, ZUHAL HAMURCU

Journal of Clinical Practice and Research - 2021;43(4):333-336

Betül Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey

 

Autophagy is a catabolic pathway meaning “self eating” that facilitates nutrient recycling from damaged and aged organelles and other impaired cellular components through lysosomal degradation. Regulation of this process has been associated with the development of cancer. It can play different roles at different tumors and developmental stages of tumors. In breast cancer, similarly, autophagy functions as a mechanism promoting survival or leading to death. Whereas, it is very important to define the role of autophagy as an effective treatment strategy in breast cancer cells. Therefore, in this review, the role of inhibited autophagy is discussed with specific RNAs targeting Beclin 1 and LC3 genes in breast cancer.